Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VREX · against 1,216 other Healthcare companies
Ranked #324 of 1,217 · scores higher than 73% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 70–79, including VREX · Click a bar to see the companies
Mainly thanks to its earnings per share growth, which is stronger than most Healthcare peers.
| Metric | VREX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 5.3% | 6.1% | 48% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -1.2% | 5.8% | 26% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 324 | 243M USD | 73 | 56 | |
| 324 | 155.7B USD | 73 | 64 | |
| 324 | 73.5B TRY (≈$2.2B) | 73 | 68 | |
| 324 | 20.5B INR (≈$246M) | 73 | 49 | |
| 324 | 787M USD | 73 | 57 | |
| 335 | 3.01T KRW (≈$2.2B) | 72 | 53 | |
| 335 | 1.21T JPY (≈$8.2B) | 72 | 74 | |
| 335 | 25.3B HKD (≈$3.2B) | 72 | 57 | |
| 335 | 8.7B CNY (≈$1.2B) | 72 | 77 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score